Role of molecular imaging in the detection of localized prostate cancer

Role of molecular imaging in the detection of localized prostate cancer

Molecular imaging of prostate cancer continues to grow, with recent inclusion of several positron emission tomography (PET) radiotracers into the recent National Comprehensive Cancer Network guidelines and the US Food and Drug Administration approval of prostate-specific membrane antigen (PSMA)-targ...

Full description

Bibliographic Details
Main Authors:	Samuel J. Galgano, Janelle T. West, Soroush Rais-Bahrami
Format:	Article
Language:	English
Published:	SAGE Publishing 2022-06-01
Series:	Therapeutic Advances in Urology
Online Access:	https://doi.org/10.1177/17562872221105018

Similar Items

Defining Oligometastatic Disease in the New Era of PSMA-PET Imaging for Primary Staging of Prostate Cancer
by: Samuel J. Galgano, et al.
Published: (2022-07-01)

Contemporary Review of Multimodality Imaging of the Prostate Gland
by: Carli E. Calderone, et al.
Published: (2023-05-01)

The Role of Imaging in Bladder Cancer Diagnosis and Staging
by: Samuel J. Galgano, et al.
Published: (2020-09-01)

Imaging as a Personalized Biomarker for Prostate Cancer Risk Stratification
by: Kyle H. Gennaro, et al.
Published: (2018-11-01)

Imaging for the Initial Staging and Post-Treatment Surveillance of Penile Squamous Cell Carcinoma
by: Samuel J. Galgano, et al.
Published: (2022-01-01)

Metastatic prostate cancer to an ischiorectal fossa lymph node identified on multiparametric magnetic resonance imaging
by: Andrew M Fang, et al.
Published: (2020-01-01)

Integration of magnetic resonance imaging into prostate cancer nomograms
by: Garrett J. Brinkley, et al.
Published: (2022-05-01)

Prostate Cancer Imaging and Biomarkers Guiding Safe Selection of Active Surveillance
by: Zachary A. Glaser, et al.
Published: (2017-10-01)

Image-guided focal therapy for prostate cancer
by: Sandeep Sankineni, et al.
Published: (2014-11-01)

Perivesical unicentric Castleman disease initially suspected to be metastatic prostate cancer
by: Patrick J Guthrie, et al.
Published: (2016-01-01)

Prostatic intraepithelial neoplasia-like ductal prostatic adenocarcinoma: A case suitable for active surveillance?
by: Soroush Rais-Bahrami, et al.
Published: (2017-01-01)

MRI/US fusion-guided prostate biopsy allows for equivalent cancer detection with significantly fewer needle cores in biopsy-naive men
by: Vidhush K. Yarlagadda, et al.
Published: (2018-05-01)

Molecular MR Imaging of Prostate Cancer
by: Avan Kader, et al.
Published: (2020-12-01)

Role of AI and Histopathological Images in Detecting Prostate Cancer: A Survey
by: Sarah M. Ayyad, et al.
Published: (2021-04-01)

A review on the role of mp-MRI for detection, localization and staging of prostate cancer
by: Ghazaleh Jamshidi, et al.
Published: (2022-09-01)

MOLECULAR IMAGING AND INTRAOPERATIVE RADIONAVIGATION IN PROSTATE CANCER
by: P. O. Rumyantsev, et al.
Published: (2021-08-01)

Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage.
by: Rouprêt, M, et al.
Published: (2007)

Targeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancer
by: Jesse D Le, et al.
Published: (2014-08-01)

Role of brachytherapy in the treatment of localized prostate cancer
by: A. D. Kaprin, et al.
Published: (2015-12-01)

Role of brachytherapy in the treatment of localized prostate cancer
by: A. D. Kaprin, et al.
Published: (2015-01-01)

Molecular assays for the detection of microRNAs in prostate cancer
by: Becker Michael M, et al.
Published: (2009-03-01)

Target definition in salvage radiotherapy for recurrent prostate cancer: the role of advanced molecular imaging
by: Gaël eAmzalag, et al.
Published: (2016-03-01)

Is it time to stage prostate cancer using molecular imaging?
by: Özer Güzel, et al.
Published: (2022-06-01)

The Application of Radiomics and AI to Molecular Imaging for Prostate Cancer
by: William Tapper, et al.
Published: (2024-03-01)

Molecular Imaging of Prostate Cancer: A Concise Synopsis
by: Hossein Jadvar
Published: (2009-03-01)

Prostate Cancer Radiogenomics—From Imaging to Molecular Characterization
by: Matteo Ferro, et al.
Published: (2021-09-01)

Imaging of prostate cancer local recurrences: why and how?
by: Adilson Prando
Published: (2010-06-01)

Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up
by: Soroush Rais-Bahrami, et al.
Published: (2014-07-01)

The Role of Multiparametric MRI in the Local Staging of Prostate Cancer
by: Tiago Oliveira, et al.
Published: (2023-09-01)

The role of radiotherapy in localised and locally advanced prostate cancer
by: Michel Bolla, et al.
Published: (2019-04-01)

Biparametric MRI detects the aggressive molecular features of prostate cancer
by: J. Norris, et al.
Published: (2020-07-01)

Early Detection of Prostate Cancer: The Role of Scent
by: Fabio Grizzi, et al.
Published: (2023-06-01)

The Role of Digital Rectal Examination Prostate Volume Category in the Early Detection of Prostate Cancer: Its Correlation with the Magnetic Resonance Imaging Prostate Volume
by: Juan Morote, et al.
Published: (2024-04-01)

Upper tract urologic LaparoEndoscopic Single-Site surgery
by: Soroush Rais-Bahrami, et al.
Published: (2012-01-01)

Artificial Intelligence Clinical Application in Prostate Cancer Molecular Imaging
by: Riccardo Laudicella, et al.
Published: (2021-03-01)

Prostate Cancer: From Molecular Imaging to Immunological and Target Therapies
by: Luca Filippi, et al.
Published: (2023-04-01)

Collagen-Specific Molecular Magnetic Resonance Imaging of Prostate Cancer
by: Avan Kader, et al.
Published: (2022-12-01)

Artificial Intelligence Clinical Application in Prostate Cancer Molecular Imaging
by: Riccardo Laudicella, et al.
Published: (2021-03-01)

The oncologic role of local treatment in primary metastatic prostate cancer.
by: Ghadjar, P, et al.
Published: (2014)

Feasibility of Dose Escalating [18F]fluciclovine Positron Emission Tomography Positive Pelvic Lymph Nodes During Moderately Hypofractionated Radiation Therapy for High-Risk Prostate Cancer
by: Andrew M. McDonald, MD, et al.
Published: (2019-10-01)